Daniel Samson, head of oligonucleotides at Bachem, gives some insight into the challenges faced when manufacturing on a large scale to meet growing demand.
Laura A. Kerepesi, PhD, associate director – Preclinical Manufacturing, Andelyn Biosciences shares insight on the key learnings from 2022 within the C> sector, as well as upcoming 2023 trends around gene therapy.
To round off the year 2022, Rebekah Jordan reflects on EPM's published stories this past year, from post-pandemic advancements to sustainability awards, along with pharma's drive towards digital transformation.
Phil Nethercote, independent pharmaceutical industry consultant and Stephanie Harden, global pharmaceutical marketing manager, Waters, discuss the types of error mitigation tools that ensure the quality of data and products among pharma companies.
Rebekah Jordan sat with Kelly Doering, AspenTech, to learn more about how digitalisation in pharma manufacturing is key to overcoming drug shortages such as this one, and how the industry can build a more resilient and flexible supply chain.
Deloitte’s Patrick Middag and Dennie van de Voort provide some practical steps to creating and entrenching effective data governance practices which in turn can help elevate the quality and value of regulated pharma data.
Here Dr. Thomas Kendall, application specialist at crystallisation and solid-state specialist Technobis Crystallization Systems, gives a perspective on the benefits of co-crystals and explains how they can be screened.
CEOs from AstraZeneca, GSK, Merck KGaA, Novo Nordisk, Roche, Samsung Biologics and Sanofi announced joint action to achieve near-term emissions reduction targets and accelerate the delivery of net zero health systems.
Alexander Krujatz, chief commercial officer, Centrient Pharmaceuticals, explains the decreasing resilience of the supply chain of essential drugs to European patients, and what can be done to safeguard the essential medicines for patients in Europe.
With AI becoming more prevalent in the pharma space, Raman Bhatnagar, Pharmaceuticals lead, Aspen Technology, explores the power of machine learning and analytics, and how this helps anticipate failure prediction in pharma manufacturing.
Dr. Sandeep Kumar, Formulation Development manager, Colorcon, sheds light on how selecting an excipient in early formulation development is critical to developing a robust scalable SOD formulation and can help the transition from capsule to tablet.
